SR One recruits an IPO vet and seasoned ops chief for the venture team. And they have some practical advice for you
A few months ago, SR One completed the long-running feat of separating from its founders at GSK, while adding a fresh $500 million fund to write the next chapter in its 35-year-long story as one of the industry’s best-known venture players. And now it’s time to expand the team.
Chris Chai, the former CFO at Principia — until Sanofi CEO Paul Hudson snapped it up recently for $3.7 billion — has just come on board along with Peter Van Vlasselaer, a well known biotech entrepreneur whose list of accomplishments includes founding Armo and taking it right through a $1.6 billion sale to Eli Lilly.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.